2023 Q4 Form 10-Q Financial Statement

#000149315223040034 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue -$2.744M -$2.668M
YoY Change -4.16% -29.95%
Cost Of Revenue $1.215M $1.220M
YoY Change 0.0% 1.43%
Gross Profit $1.244M $250.0K
YoY Change 402.41% -136.59%
Gross Profit Margin
Selling, General & Admin $3.688M $2.560M
YoY Change 34.11% -2.97%
% of Gross Profit 296.35% 1024.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $5.204M $4.134M
YoY Change 20.29% -4.49%
Operating Profit -$3.959M -$3.884M
YoY Change -2.92% -22.5%
Interest Expense -$6.379M $1.215M
YoY Change -33.05% 1.04%
% of Operating Profit
Other Income/Expense, Net $356.5K
YoY Change -26.89%
Pretax Income -$9.123M $25.19M
YoY Change -26.38% -154.88%
Income Tax
% Of Pretax Income
Net Earnings -$9.123M $25.19M
YoY Change -26.38% -154.88%
Net Earnings / Revenue
Basic Earnings Per Share -$0.36 $0.99
Diluted Earnings Per Share -$0.36 $0.99
COMMON SHARES
Basic Shares Outstanding 25.21M shares 25.40M shares
Diluted Shares Outstanding 25.25M shares 25.35M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.18M $73.50M
YoY Change -29.76% 85.36%
Cash & Equivalents $28.18M $73.50M
Short-Term Investments
Other Short-Term Assets $494.6K $700.0K
YoY Change -31.97% -21.27%
Inventory
Prepaid Expenses
Receivables $132.6K $100.0K
Other Receivables $309.3K $300.0K
Total Short-Term Assets $29.11M $74.60M
YoY Change -30.03% 80.56%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $247.9M $213.8M
YoY Change 2.33% -16.8%
Other Assets $594.7K $600.0K
YoY Change 7.01% 4.75%
Total Long-Term Assets $248.5M $214.4M
YoY Change 2.34% -16.76%
TOTAL ASSETS
Total Short-Term Assets $29.11M $74.60M
Total Long-Term Assets $248.5M $214.4M
Total Assets $277.6M $289.0M
YoY Change -2.39% -3.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $346.3K $3.200M
YoY Change -51.14% -6.74%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $498.8K $3.400M
YoY Change -50.37% -10.08%
LONG-TERM LIABILITIES
Long-Term Debt $73.75M $73.70M
YoY Change 0.49% 0.55%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $73.75M $73.70M
YoY Change 0.49% 0.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $498.8K $3.400M
Total Long-Term Liabilities $73.75M $73.70M
Total Liabilities $74.24M $77.01M
YoY Change -0.2% -0.09%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $254.5K $252.1K
YoY Change -10.5% -11.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $203.4M $212.0M
YoY Change
Total Liabilities & Shareholders Equity $277.6M $289.0M
YoY Change -2.39% -3.3%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$9.123M $25.19M
YoY Change -26.38% -154.88%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$45.29M $49.70M
YoY Change -8830.43% -149.63%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -35.83K -700.0K
YoY Change -33.35% -94.7%
NET CHANGE
Cash From Operating Activities -45.29M 49.70M
Cash From Investing Activities
Cash From Financing Activities -35.83K -700.0K
Net Change In Cash -45.32M 49.00M
YoY Change -9847.5% -143.24%
FREE CASH FLOW
Cash From Operating Activities -$45.29M $49.70M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
3162468 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.92
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-4443543
dei Entity Address Address Line1
EntityAddressAddressLine1
640 Fifth Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
12th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10019
dei City Area Code
CityAreaCode
(212)
dei Local Phone Number
LocalPhoneNumber
931-6331
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Central Index Key
EntityCentralIndexKey
0001509470
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 SSSS Investment Company Dividend Declared
InvestmentCompanyDividendDeclared
usd
CY2023Q1 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
usd
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
shares
SSSS Accrued Interest On Us Treasury Bills
AccruedInterestOnUSTreasuryBills
usd
SSSS Proceeds From Sales Or Maturity Of Investments Us Treasury Bills
ProceedsFromSalesOrMaturityOfInvestmentsUSTreasuryBills
usd
SSSS Increase Decrease In Proceeds Receivable
IncreaseDecreaseInProceedsReceivable
usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
usd
CY2023Q3 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
CY2022Q3 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
CY2023Q3 SSSS Investment Company Issuance Offering Per Share
InvestmentCompanyIssuanceOfferingPerShare
CY2022Q3 SSSS Investment Company Issuance Offering Per Share
InvestmentCompanyIssuanceOfferingPerShare
SSSS Investment Company Issuance Offering Per Share
InvestmentCompanyIssuanceOfferingPerShare
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
814-00852
dei Entity Registrant Name
EntityRegistrantName
SuRo Capital Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25209108 shares
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
193492718 usd
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
157188578 usd
CY2023Q3 SSSS Investments In U.S.Treasury Bills Cost
InvestmentsInU.s.TreasuryBillsCost
20265064 usd
CY2022Q4 SSSS Investments In U.S.Treasury Bills Cost
InvestmentsInU.s.TreasuryBillsCost
85056817 usd
CY2023Q3 us-gaap Investments
Investments
213757782 usd
CY2022Q4 us-gaap Investments
Investments
242245395 usd
CY2023Q3 us-gaap Cash
Cash
73503279 usd
CY2022Q4 us-gaap Cash
Cash
40117598 usd
CY2023Q3 SSSS Escrow Proceeds Receivable
EscrowProceedsReceivable
309484 usd
CY2022Q4 SSSS Escrow Proceeds Receivable
EscrowProceedsReceivable
628332 usd
CY2023Q3 SSSS Interest And Dividends Receivable
InterestAndDividendsReceivable
100860 usd
CY2022Q4 SSSS Interest And Dividends Receivable
InterestAndDividendsReceivable
138766 usd
CY2023Q3 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
611736 usd
CY2022Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
555761 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
693687 usd
CY2023Q3 us-gaap Assets
Assets
288976828 usd
CY2022Q4 us-gaap Assets
Assets
284412858 usd
CY2023Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
188357 usd
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
296170 usd
CY2023Q3 us-gaap Notes Payable
NotesPayable
73654960 usd
CY2023Q3 us-gaap Liabilities
Liabilities
77005785 usd
CY2022Q4 us-gaap Liabilities
Liabilities
74392156 usd
CY2023Q3 us-gaap Assets Net
AssetsNet
211971043 usd
CY2022Q4 us-gaap Assets Net
AssetsNet
210020702 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25209108 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25209108 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28429499 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28429499 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
252091 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
284295 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
318691954 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
330899254 usd
CY2023Q3 SSSS Accumulated Net Investment Loss
AccumulatedNetInvestmentLoss
-75528136 usd
CY2022Q4 SSSS Accumulated Net Investment Loss
AccumulatedNetInvestmentLoss
-64832605 usd
CY2023Q3 SSSS Accumulated Net Realized Gain On Investments Net Of Distributions
AccumulatedNetRealizedGainOnInvestmentsNetOfDistributions
-11989672 usd
CY2022Q4 SSSS Accumulated Net Realized Gain On Investments Net Of Distributions
AccumulatedNetRealizedGainOnInvestmentsNetOfDistributions
2552465 usd
CY2023Q3 SSSS Accumulated Net Unrealized Depreciation Appreciation Of Investments
AccumulatedNetUnrealizedDepreciationAppreciationOfInvestments
-19455194 usd
CY2022Q4 SSSS Accumulated Net Unrealized Depreciation Appreciation Of Investments
AccumulatedNetUnrealizedDepreciationAppreciationOfInvestments
-58882707 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
211971043 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
210020702 usd
CY2023Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
8.41
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
7.39
CY2023Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0600 pure
CY2023Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0653 pure
CY2023Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
75000000 usd
CY2022Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0600 pure
CY2022Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0653 pure
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
75000000 usd
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
1465746 usd
CY2022Q3 us-gaap Investment Income Net
InvestmentIncomeNet
519511 usd
us-gaap Investment Income Net
InvestmentIncomeNet
4137046 usd
us-gaap Investment Income Net
InvestmentIncomeNet
1993242 usd
CY2023Q3 us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
2123704 usd
CY2022Q3 us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
1836808 usd
us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
6378330 usd
us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
5456771 usd
CY2023Q3 SSSS Directors Fees
DirectorsFees
161661 usd
CY2022Q3 SSSS Directors Fees
DirectorsFees
161661 usd
SSSS Directors Fees
DirectorsFees
483887 usd
SSSS Directors Fees
DirectorsFees
514055 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
277075 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
565411 usd
us-gaap Professional Fees
ProfessionalFees
2184488 usd
us-gaap Professional Fees
ProfessionalFees
2916583 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
1215248 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
1202748 usd
us-gaap Interest Expense
InterestExpense
3642801 usd
us-gaap Interest Expense
InterestExpense
3630301 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
74497 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
620606 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
82238 usd
CY2023Q3 us-gaap Other Expenses
OtherExpenses
356484 usd
CY2022Q3 us-gaap Other Expenses
OtherExpenses
487619 usd
us-gaap Other Expenses
OtherExpenses
1522465 usd
us-gaap Other Expenses
OtherExpenses
1238120 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
4134172 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
4328744 usd
us-gaap Operating Expenses
OperatingExpenses
14832577 usd
us-gaap Operating Expenses
OperatingExpenses
13838068 usd
CY2023Q3 us-gaap Net Investment Income
NetInvestmentIncome
-2668426 usd
CY2022Q3 us-gaap Net Investment Income
NetInvestmentIncome
-3809233 usd
us-gaap Net Investment Income
NetInvestmentIncome
-10695531 usd
us-gaap Net Investment Income
NetInvestmentIncome
-11844826 usd
CY2023Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-1461281 usd
CY2022Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-5141097 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-14542137 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-4011047 usd
CY2023Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
29323067 usd
CY2022Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-36951920 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
39427513 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-103929610 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
25193360 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-45902250 usd
us-gaap Net Income Loss
NetIncomeLoss
14189845 usd
us-gaap Net Income Loss
NetIncomeLoss
-119785483 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.99
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.92
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25351306 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29781801 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26549672 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30542611 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25351306 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29781801 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26549672 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30542611 shares
CY2022Q4 us-gaap Assets Net
AssetsNet
210020702 usd
CY2021Q4 us-gaap Assets Net
AssetsNet
364846624 usd
CY2023Q1 us-gaap Net Investment Income
NetInvestmentIncome
-4221765 usd
CY2022Q1 us-gaap Net Investment Income
NetInvestmentIncome
-4224705 usd
CY2023Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
189343 usd
CY2022Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
3096275 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
8648931 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
21584885 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
4616509 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
20456455 usd
CY2022Q1 SSSS Investment Company Dividend Declared
InvestmentCompanyDividendDeclared
3441824 usd
CY2022Q1 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
3441824 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
229896 usd
CY2023Q1 SSSS Stock Issued During Period Values Share Based Compensation Gross
StockIssuedDuringPeriodValuesShareBasedCompensationGross
405858 usd
CY2022Q1 SSSS Stock Issued During Period Values Share Based Compensation Gross
StockIssuedDuringPeriodValuesShareBasedCompensationGross
-30016 usd
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1359607 usd
CY2023Q1 SSSS Investment Company Capital Share Transactions
InvestmentCompanyCapitalShareTransactions
405858 usd
CY2022Q1 SSSS Investment Company Capital Share Transactions
InvestmentCompanyCapitalShareTransactions
-1159727 usd
CY2023Q1 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
5022367 usd
CY2022Q1 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
15854904 usd
CY2023Q1 us-gaap Assets Net
AssetsNet
215043069 usd
CY2022Q1 us-gaap Assets Net
AssetsNet
380701528 usd
CY2023Q2 us-gaap Net Investment Income
NetInvestmentIncome
-3805340 usd
CY2022Q2 us-gaap Net Investment Income
NetInvestmentIncome
-3810888 usd
CY2023Q2 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-13270199 usd
CY2022Q2 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-1966225 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
1455515 usd
CY2022Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-88562575 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-15620024 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-94339688 usd
CY2023Q2 SSSS Stock Issued During Period Values Share Based Compensation Gross
StockIssuedDuringPeriodValuesShareBasedCompensationGross
769679 usd
CY2022Q2 SSSS Stock Issued During Period Values Share Based Compensation Gross
StockIssuedDuringPeriodValuesShareBasedCompensationGross
703566 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
13500000 usd
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
6892934 usd
CY2023Q2 SSSS Investment Company Capital Share Transactions
InvestmentCompanyCapitalShareTransactions
-12730321 usd
CY2022Q2 SSSS Investment Company Capital Share Transactions
InvestmentCompanyCapitalShareTransactions
-6189368 usd
CY2023Q2 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-28350345 usd
CY2022Q2 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-100529056 usd
CY2023Q2 us-gaap Assets Net
AssetsNet
186692724 usd
CY2022Q2 us-gaap Assets Net
AssetsNet
280172472 usd
CY2023Q3 us-gaap Net Investment Income
NetInvestmentIncome
-2668426 usd
CY2022Q3 us-gaap Net Investment Income
NetInvestmentIncome
-3809233 usd
CY2023Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-1461281 usd
CY2022Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-5141097 usd
CY2023Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
29323067 usd
CY2022Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-36951920 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
25193360 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-45902250 usd
CY2023Q3 SSSS Stock Issued During Period Values Share Based Compensation Gross
StockIssuedDuringPeriodValuesShareBasedCompensationGross
763644 usd
CY2022Q3 SSSS Stock Issued During Period Values Share Based Compensation Gross
StockIssuedDuringPeriodValuesShareBasedCompensationGross
713389 usd
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
678685 usd
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
13200000 usd
CY2023Q3 SSSS Investment Company Capital Share Transactions
InvestmentCompanyCapitalShareTransactions
84959 usd
CY2022Q3 SSSS Investment Company Capital Share Transactions
InvestmentCompanyCapitalShareTransactions
-12486611 usd
CY2023Q3 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
25278319 usd
CY2022Q3 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-58388861 usd
CY2023Q3 us-gaap Assets Net
AssetsNet
211971043 usd
CY2022Q3 us-gaap Assets Net
AssetsNet
221783611 usd
CY2022Q4 us-gaap Shares Outstanding
SharesOutstanding
28429499 shares
CY2021Q4 us-gaap Shares Outstanding
SharesOutstanding
31118556 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
17807 shares
us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
33898 shares
us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
205974 shares
SSSS Stock Repurchased For Capital Share Activity
StockRepurchasedForCapitalShareActivity
-3186493 shares
SSSS Stock Repurchased For Capital Share Activity
StockRepurchasedForCapitalShareActivity
-3008676 shares
CY2023Q3 us-gaap Shares Outstanding
SharesOutstanding
25209108 shares
CY2022Q3 us-gaap Shares Outstanding
SharesOutstanding
28333661 shares
us-gaap Net Income Loss
NetIncomeLoss
14189845 usd
us-gaap Net Income Loss
NetIncomeLoss
-119785483 usd
SSSS Realized Investment Gain Losses
RealizedInvestmentGainLosses
-14542137 usd
SSSS Realized Investment Gain Losses
RealizedInvestmentGainLosses
-4011047 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
39427513 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-103929610 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
211835 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
318289 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1939181 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1386939 usd
SSSS Adjustments To Escrow Proceeds Receivable
AdjustmentsToEscrowProceedsReceivable
116052 usd
SSSS Adjustments To Escrow Proceeds Receivable
AdjustmentsToEscrowProceedsReceivable
-855758 usd
SSSS Accrued Interest On Us Treasury Bills
AccruedInterestOnUSTreasuryBills
243674 usd
SSSS Purchases Of Portfolio Investments
PurchasesOfPortfolioInvestments
19836933 usd
SSSS Purchases Of Portfolio Investments
PurchasesOfPortfolioInvestments
12526206 usd
SSSS Purchases Of Us Treasury Bills Investments
PurchasesOfUSTreasuryBillsInvestments
141793045 usd
SSSS Purchases Of Us Treasury Bills Investments
PurchasesOfUSTreasuryBillsInvestments
99173075 usd
SSSS Proceeds From Sales Or Maturity Of Investments Portfolio Investments
ProceedsFromSalesOrMaturityOfInvestmentsPortfolioInvestments
8328163 usd
SSSS Proceeds From Sales Or Maturity Of Investments Portfolio Investments
ProceedsFromSalesOrMaturityOfInvestmentsPortfolioInvestments
7776744 usd
SSSS Proceeds From Sales Or Maturity Of Investments Us Treasury Bills
ProceedsFromSalesOrMaturityOfInvestmentsUSTreasuryBills
206802427 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-33319 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-48810 usd
us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
-37906 usd
us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
35953 usd
SSSS Increase Decrease In Proceeds Receivable
IncreaseDecreaseInProceedsReceivable
-52493 usd
SSSS Increase Decrease In Escrow Proceeds Receivable
IncreaseDecreaseInEscrowProceedsReceivable
-318848 usd
SSSS Increase Decrease In Escrow Proceeds Receivable
IncreaseDecreaseInEscrowProceedsReceivable
-1392854 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2453641 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2556347 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-175000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
47672189 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-111078342 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
229896 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
14178685 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
21452541 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
107823 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
26481943 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1540 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-14286508 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-47706128 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
33385681 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-158784470 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
40117598 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
198437078 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
73503279 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
39652608 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_80B_eus-gaap--NatureOfOperations_zPYR7AejPY6a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1—<span id="xdx_824_z4xhD3cMaClb">NATURE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SuRo Capital Corp. (“we”, “us”, “our”, “Company” or “SuRo Capital”), formerly known as Sutter Rock Capital Corp. and as GSV Capital Corp. and formed in September 2010 as a Maryland corporation, is an internally-managed, non-diversified closed-end management investment company. The Company has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”), and has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s date of inception was January 6, 2011, which is the date we commenced development stage activities. The Company’s common stock is currently listed on the Nasdaq Global Select Market under the symbol “SSSS” (formerly “GSVC”). Prior to November 24, 2021, our common stock traded on the Nasdaq Capital Market under the same symbol (“SSSS”). The Company began its investment operations during the second quarter of 2011.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below displays the Company’s subsidiaries as of September 30, 2023, which, other than GSV Capital Lending, LLC (“GCL”) and SuRo Capital Sports, LLC, are collectively referred to as the “Taxable Subsidiaries.” The Taxable Subsidiaries were formed to hold certain portfolio investments. The Taxable Subsidiaries, including their associated portfolio investments, are consolidated with the Company for accounting purposes, but have elected to be treated as separate entities for U.S. federal income tax purposes. GCL was formed to originate portfolio loan investments within the state of California and is consolidated with the Company for accounting purposes. Refer to “Note 2—Significant Accounting Policies—<i>Basis of Consolidation</i>” below for further detail.</span></p> <p id="xdx_896_ecustom--ScheduleOfSubsidiariesOfCompanyTableTextBlock_zzDomfXS2yle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span id="xdx_8B6_zNviInclZXX5" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF COMPANY’S SUBSIDIARIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Subsidiary</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Jurisdiction of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation</b></span></p></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Formation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></p></td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Owned</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">GCL</td><td style="width: 2%"> </td> <td id="xdx_98E_edei--EntityIncorporationStateCountryCode_c20230101__20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GCLMember_zyU3pgtMxr05" style="width: 16%; text-align: center" title="Jurisdiction of Incorporation">Delaware</td><td style="width: 2%"> </td> <td id="xdx_98B_edei--EntityIncorporationDateOfIncorporation_c20230101__20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GCLMember_zrgy3puoPbh9" style="width: 16%; text-align: center" title="Formation Date">April 13, 2012</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GCLMember_zOxpAceiI5k5" style="width: 14%; text-align: right" title="Percentage Owned">100</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">SuRo Capital Sports, LLC (“SuRo Sports”)</td><td> </td> <td id="xdx_98E_edei--EntityIncorporationStateCountryCode_c20230101__20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SuRoCapitalSportsLLCSuRoSportsMember_zTdzQnfUvbFh" style="text-align: center" title="Jurisdiction of Incorporation">Delaware</td><td> </td> <td id="xdx_98A_edei--EntityIncorporationDateOfIncorporation_c20230101__20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SuRoCapitalSportsLLCSuRoSportsMember_zT57fz7gvfN3" style="text-align: center" title="Formation Date">March 19, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SuRoCapitalSportsLLCSuRoSportsMember_zzw9vw54zRS6" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Subsidiaries below are referred to collectively as the “Taxable Subsidiaries”</td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">GSVC AE Holdings, Inc. (“GAE”)</td><td> </td> <td id="xdx_989_edei--EntityIncorporationStateCountryCode_c20230101__20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAEHoldingsIncGAEMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zGThjDzMrqCc" style="text-align: center" title="Jurisdiction of Incorporation">Delaware</td><td> </td> <td id="xdx_980_edei--EntityIncorporationDateOfIncorporation_c20230101__20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAEHoldingsIncGAEMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zeGwJj5m5nab" style="text-align: center" title="Formation Date">November 28, 2012</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAEHoldingsIncGAEMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zO33CbpAVYN1" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">GSVC AV Holdings, Inc. (“GAV”)</td><td> </td> <td id="xdx_982_edei--EntityIncorporationStateCountryCode_c20230101__20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAVHoldingsIncGAVMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_z9z40SmzyHj4" style="text-align: center" title="Jurisdiction of Incorporation">Delaware</td><td> </td> <td id="xdx_980_edei--EntityIncorporationDateOfIncorporation_c20230101__20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAVHoldingsIncGAVMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zQpsbhmAL9g2" style="text-align: center" title="Formation Date">November 28, 2012</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAVHoldingsIncGAVMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_z5kxmeUJ8SZ" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">GSVC SW Holdings, Inc. (“GSW”)</td><td> </td> <td id="xdx_98B_edei--EntityIncorporationStateCountryCode_c20230101__20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSWHoldingsIncGSWMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zH8tTUpfd1ob" style="text-align: center" title="Jurisdiction of Incorporation">Delaware</td><td> </td> <td id="xdx_98E_edei--EntityIncorporationDateOfIncorporation_c20230101__20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSWHoldingsIncGSWMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_z5UOdiDFLAmg" style="text-align: center" title="Formation Date">November 28, 2012</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSWHoldingsIncGSWMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zNhY0EO477w6" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">GSVC SVDS Holdings, Inc. (“SVDS”)</td><td> </td> <td id="xdx_98C_edei--EntityIncorporationStateCountryCode_c20230101__20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSVDSHoldingsIncSVDSMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zzT7JnAHpNxi" style="text-align: center" title="Jurisdiction of Incorporation">Delaware</td><td> </td> <td id="xdx_98A_edei--EntityIncorporationDateOfIncorporation_c20230101__20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSVDSHoldingsIncSVDSMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zuMcguhDK9q4" style="text-align: center" title="Formation Date">August 13, 2013</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSVDSHoldingsIncSVDSMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zA6DkGF3Dtz1" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8A7_zNIlhb1XoOz" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s investment objective is to maximize its portfolio’s total return, principally by seeking capital gains on its equity and equity-related investments, and to a lesser extent, income from debt investments. The Company invests principally in the equity securities of what it believes to be rapidly growing venture-capital-backed emerging companies. The Company may invest in these portfolio companies through offerings of the prospective portfolio companies, transactions on secondary marketplaces for private companies, or negotiations with selling stockholders. In addition, the Company may invest in private credit and in founders equity, founders warrants, forward purchase agreements, and private investment in public equity transactions of special purpose acquisition companies. The Company may also invest on an opportunistic basis in select publicly traded equity securities or certain non-U.S. companies that otherwise meet its investment criteria, subject to any applicable limitations under the 1940 Act.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SURO CAPITAL CORP. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_z6VEsJ248RX4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zBGMcGlzdXld">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of condensed consolidated financial statements in accordance with GAAP requires the Company’s management to make a number of significant estimates. These include estimates of the fair value of certain assets and liabilities and other estimates that affect the reported amounts of certain assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of certain revenues and expenses during the reporting period. It is likely that changes in these estimates may occur in the near term. The Company’s estimates are inherently subjective in nature and actual results could differ materially from such estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023Q3 SSSS Escrow Proceeds Receivable
EscrowProceedsReceivable
309484 usd
CY2022Q4 SSSS Escrow Proceeds Receivable
EscrowProceedsReceivable
628332 usd
CY2023Q3 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
611736 usd
CY2022Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
555761 usd
CY2019Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2023Q3 us-gaap Escrow Deposit
EscrowDeposit
0 usd
CY2022Q4 us-gaap Escrow Deposit
EscrowDeposit
0 usd
CY2023Q3 SSSS Number Of Positions
NumberOfPositions
66
CY2023Q3 SSSS Number Of Portfolio Companies
NumberOfPortfolioCompanies
39
CY2022Q4 SSSS Number Of Positions
NumberOfPositions
64
CY2022Q4 SSSS Number Of Portfolio Companies
NumberOfPortfolioCompanies
39
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
193492718 usd
CY2023Q3 SSSS Investment Owned Percent Of Investment Portfolio
InvestmentOwnedPercentOfInvestmentPortfolio
1.000 pure
CY2023Q3 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.912 pure
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
157188578 usd
CY2022Q4 SSSS Investment Owned Percent Of Investment Portfolio
InvestmentOwnedPercentOfInvestmentPortfolio
1.000 pure
CY2022Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.748 pure
CY2023Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
193492718 usd
CY2023Q3 SSSS Investment Owned Percent Of Investment Portfolio
InvestmentOwnedPercentOfInvestmentPortfolio
1.000 pure
CY2023Q3 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.912 pure
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
157188578 usd
CY2022Q4 SSSS Investment Owned Percent Of Investment Portfolio
InvestmentOwnedPercentOfInvestmentPortfolio
1.000 pure
CY2022Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.748 pure
CY2023Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
213757782 usd
CY2022Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
242245395 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
143865093 usd
SSSS Transfers
Transfers
-2711842 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
19836933 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
-1002629 usd
SSSS Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Exercises And Conversions
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisExercisesAndConversions
30820 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-9615023 usd
SSSS Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain And Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainAndLoss
17098368 usd
CY2023Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
167501720 usd
SSSS Fair Value Asset Recurring Basis Still Held Unrealized Gain And Loss Oci
FairValueAssetRecurringBasisStillHeldUnrealizedGainAndLossOci
6151678 usd
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
214632504 usd
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
214632504 usd
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
8742396 usd
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
22780064 usd
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
-1874470 usd
CY2022 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
90586 usd
CY2022 SSSS Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain And Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainAndLoss
-83021195 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
143865093 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
143865093 usd
CY2022 SSSS Fair Value Asset Recurring Basis Still Held Unrealized Gain And Loss Oci
FairValueAssetRecurringBasisStillHeldUnrealizedGainAndLossOci
-70818192 usd
CY2023Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
60000000.0 usd
CY2023Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
186493 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
186493 shares
CY2022Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1008676 shares
CY2023Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
25193360 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-45902250 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
14189845 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-119785483 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25351306 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29781801 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26549672 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30542611 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.99
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.92
CY2023Q3 SSSS Income Loss From Continuing Operations Diluted
IncomeLossFromContinuingOperationsDiluted
25193360 usd
CY2022Q3 SSSS Income Loss From Continuing Operations Diluted
IncomeLossFromContinuingOperationsDiluted
-45902250 usd
SSSS Income Loss From Continuing Operations Diluted
IncomeLossFromContinuingOperationsDiluted
14189845 usd
SSSS Income Loss From Continuing Operations Diluted
IncomeLossFromContinuingOperationsDiluted
-119785483 usd
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25351306 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29781801 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26549672 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30542611 shares
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.99
CY2023Q3 SSSS Investment Company Share Based Compensation Arrangement By Share Based Payment
InvestmentCompanyShareBasedCompensationArrangementByShareBasedPayment
0.03
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.92
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2024-07-31
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
159693 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
288268 usd
CY2023Q3 us-gaap Security Deposit
SecurityDeposit
16574 usd
CY2022Q4 us-gaap Security Deposit
SecurityDeposit
16574 usd
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
52472 usd
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
48738 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
151637 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
143459 usd
CY2023Q3 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P0Y9M18D
CY2023Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0300 pure
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
48273 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
113603 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
161876 usd
CY2023Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
7.35
CY2022Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
9.24
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
7.39
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
11.72
CY2023Q3 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.11
CY2022Q3 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.13
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.40
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.39
CY2023Q3 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
-0.06
CY2022Q3 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
-0.17
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
-0.55
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
-0.13
CY2023Q3 SSSS Investment Company Unrealized Investment Income Loss From Operations Per Share
InvestmentCompanyUnrealizedInvestmentIncomeLossFromOperationsPerShare
1.16
CY2022Q3 SSSS Investment Company Unrealized Investment Income Loss From Operations Per Share
InvestmentCompanyUnrealizedInvestmentIncomeLossFromOperationsPerShare
-1.24
SSSS Investment Company Unrealized Investment Income Loss From Operations Per Share
InvestmentCompanyUnrealizedInvestmentIncomeLossFromOperationsPerShare
1.49
SSSS Investment Company Unrealized Investment Income Loss From Operations Per Share
InvestmentCompanyUnrealizedInvestmentIncomeLossFromOperationsPerShare
-3.40
us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.11
SSSS Investment Company Issuance Offering Per Share
InvestmentCompanyIssuanceOfferingPerShare
0.01
CY2023Q3 SSSS Investment Company Repurchase Per Share
InvestmentCompanyRepurchasePerShare
0.04
CY2022Q3 SSSS Investment Company Repurchase Per Share
InvestmentCompanyRepurchasePerShare
0.11
SSSS Investment Company Repurchase Per Share
InvestmentCompanyRepurchasePerShare
0.41
SSSS Investment Company Repurchase Per Share
InvestmentCompanyRepurchasePerShare
0.08
CY2022Q3 SSSS Investment Company Share Based Compensation Arrangement By Share Based Payment
InvestmentCompanyShareBasedCompensationArrangementByShareBasedPayment
0.02
SSSS Investment Company Share Based Compensation Arrangement By Share Based Payment
InvestmentCompanyShareBasedCompensationArrangementByShareBasedPayment
0.07
SSSS Investment Company Share Based Compensation Arrangement By Share Based Payment
InvestmentCompanyShareBasedCompensationArrangementByShareBasedPayment
0.05
CY2023Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
8.41
CY2022Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
7.83
CY2023Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
8.41
CY2022Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
7.83
CY2023Q3 SSSS Market Value Value Per Share
MarketValueValuePerShare
3.62
CY2022Q3 SSSS Market Value Value Per Share
MarketValueValuePerShare
3.87
CY2023Q3 SSSS Market Value Value Per Share
MarketValueValuePerShare
3.62
CY2022Q3 SSSS Market Value Value Per Share
MarketValueValuePerShare
3.87
CY2023Q3 SSSS Investment Company Total Return Basedon Market Value
InvestmentCompanyTotalReturnBasedonMarketValue
0.1313 pure
CY2022Q3 SSSS Investment Company Total Return Basedon Market Value
InvestmentCompanyTotalReturnBasedonMarketValue
-0.3953 pure
SSSS Investment Company Total Return Basedon Market Value
InvestmentCompanyTotalReturnBasedonMarketValue
-0.0474 pure
SSSS Investment Company Total Return Basedon Market Value
InvestmentCompanyTotalReturnBasedonMarketValue
-0.6891 pure
CY2023Q3 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.1442 pure
CY2022Q3 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.1526 pure
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.1380 pure
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.3225 pure
CY2023Q3 us-gaap Shares Outstanding
SharesOutstanding
25209108 shares
CY2022Q3 us-gaap Shares Outstanding
SharesOutstanding
28333661 shares
CY2023Q3 us-gaap Shares Outstanding
SharesOutstanding
25209108 shares
CY2022Q3 us-gaap Shares Outstanding
SharesOutstanding
28333661 shares
CY2023Q3 us-gaap Assets Net
AssetsNet
211971043 usd
CY2022Q3 us-gaap Assets Net
AssetsNet
221783611 usd
CY2023Q3 us-gaap Assets Net
AssetsNet
211971043 usd
CY2022Q3 us-gaap Assets Net
AssetsNet
221783611 usd
CY2023Q3 SSSS Average Net Asset
AverageNetAsset
204284971 usd
CY2022Q3 SSSS Average Net Asset
AverageNetAsset
278994914 usd
SSSS Average Net Asset
AverageNetAsset
206224853 usd
SSSS Average Net Asset
AverageNetAsset
340160110 usd
CY2023Q3 us-gaap Investment Company Expense Ratio After Incentive Allocation
InvestmentCompanyExpenseRatioAfterIncentiveAllocation
0.0803 pure
CY2022Q3 us-gaap Investment Company Expense Ratio After Incentive Allocation
InvestmentCompanyExpenseRatioAfterIncentiveAllocation
0.0514 pure
us-gaap Investment Company Expense Ratio After Incentive Allocation
InvestmentCompanyExpenseRatioAfterIncentiveAllocation
0.0962 pure
us-gaap Investment Company Expense Ratio After Incentive Allocation
InvestmentCompanyExpenseRatioAfterIncentiveAllocation
0.0489 pure
CY2023Q3 us-gaap Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
-0.0518 pure
CY2022Q3 us-gaap Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
-0.0466 pure
us-gaap Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
-0.0693 pure
us-gaap Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
-0.0452 pure
CY2023Q3 SSSS Investment Company Turnover Ratio After Incentive Allocation
InvestmentCompanyTurnoverRatioAfterIncentiveAllocation
0.0117 pure
CY2022Q3 SSSS Investment Company Turnover Ratio After Incentive Allocation
InvestmentCompanyTurnoverRatioAfterIncentiveAllocation
0.0085 pure
SSSS Investment Company Turnover Ratio After Incentive Allocation
InvestmentCompanyTurnoverRatioAfterIncentiveAllocation
0.0493 pure
SSSS Investment Company Turnover Ratio After Incentive Allocation
InvestmentCompanyTurnoverRatioAfterIncentiveAllocation
0.0347 pure
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.04 pure
us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
(1) 98% of our ordinary income (taking into account certain deferrals and elections) for each calendar year, (2) 98.2% of our capital gain net income (adjusted for certain ordinary losses) for the 1-year period ending October 31 of each such calendar year and (3) any ordinary income and net capital gains for preceding years, but not distributed during such years and on which the Company paid no U.S. federal income tax
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.04 pure
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y6M18D
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.3947 pure
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0186 pure
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1155000 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.57
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.57
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
385000 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
6.57
CY2019Q4 SSSS Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Exercisable Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExercisableWeightedAverageGrantDateFairValue
2.57
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1155000 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1155000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.57
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.57
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue
2.57
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue
2.57
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001493152-23-040034-index-headers.html Edgar Link pending
0001493152-23-040034-index.html Edgar Link pending
0001493152-23-040034.txt Edgar Link pending
0001493152-23-040034-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ssss-20230930.xsd Edgar Link pending
ssss-20230930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ssss-20230930_def.xml Edgar Link unprocessable
ssss-20230930_cal.xml Edgar Link unprocessable
ssss-20230930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed